Vincerx Pharma Inc (VINC)
0.8771
-0.05
(-5.69%)
USD |
NASDAQ |
May 03, 16:00
0.877
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma Price: 0.8771 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 0.9272 | 0.935 | 0.8511 | 0.8771 | 309591.0 |
May 02, 2024 | 0.86 | 0.93 | 0.8570 | 0.93 | 252116.0 |
May 01, 2024 | 0.82 | 0.8892 | 0.80 | 0.8892 | 300820.0 |
Apr 30, 2024 | 0.859 | 0.9039 | 0.815 | 0.827 | 318867.0 |
Apr 29, 2024 | 0.737 | 0.88 | 0.737 | 0.8401 | 728639.0 |
Apr 26, 2024 | 0.79 | 0.846 | 0.6607 | 0.73 | 1.729M |
Apr 25, 2024 | 0.92 | 0.93 | 0.88 | 0.8967 | 609247.0 |
Apr 24, 2024 | 0.9658 | 0.9942 | 0.90 | 0.93 | 458044.0 |
Apr 23, 2024 | 0.87 | 0.9895 | 0.869 | 0.95 | 420864.0 |
Apr 22, 2024 | 0.88 | 0.88 | 0.82 | 0.869 | 325003.0 |
Apr 19, 2024 | 0.8767 | 0.9071 | 0.8259 | 0.85 | 356030.0 |
Apr 18, 2024 | 0.9499 | 0.9499 | 0.8526 | 0.90 | 531361.0 |
Apr 17, 2024 | 0.93 | 0.9804 | 0.91 | 0.9502 | 358138.0 |
Apr 16, 2024 | 0.8589 | 0.9668 | 0.85 | 0.9397 | 911198.0 |
Apr 15, 2024 | 0.95 | 0.9701 | 0.75 | 0.87 | 1.266M |
Apr 12, 2024 | 1.01 | 1.01 | 0.95 | 0.98 | 913245.0 |
Apr 11, 2024 | 1.00 | 1.04 | 0.905 | 1.00 | 2.324M |
Apr 10, 2024 | 1.00 | 1.16 | 0.9701 | 1.00 | 4.078M |
Apr 09, 2024 | 1.64 | 1.654 | 1.05 | 1.06 | 15.39M |
Apr 08, 2024 | 5.56 | 5.67 | 4.69 | 4.78 | 2.220M |
Apr 05, 2024 | 5.92 | 6.07 | 4.83 | 5.55 | 687152.0 |
Apr 04, 2024 | 6.62 | 6.84 | 5.86 | 5.92 | 436166.0 |
Apr 03, 2024 | 6.42 | 6.84 | 6.01 | 6.60 | 417634.0 |
Apr 02, 2024 | 5.57 | 6.44 | 5.557 | 6.37 | 707698.0 |
Apr 01, 2024 | 4.89 | 5.99 | 4.59 | 5.85 | 940536.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.625
Minimum
Dec 18 2023
25.90
Maximum
Mar 16 2021
7.072
Average
3.905
Median
Price Benchmarks
Trxade Health Inc | 6.29 |
MyMD Pharmaceuticals Inc | 3.33 |
Acrivon Therapeutics Inc | 9.59 |
Ligand Pharmaceuticals Inc | 73.90 |
Regulus Therapeutics Inc | 2.65 |
Price Related Metrics
Price to Book Value | 1.674 |
Earnings Yield | -215.5% |
Market Cap | 18.78M |